Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-10 of 10
Keywords: Antiphospholipid antibodies
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1993) 23 (5): 275–283.
Published Online: 28 April 2009
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Systemic lupus erythematosus Antiphospholipid antibodies Lupus...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 4): 340–357.
Published Online: 28 April 2009
...L.O. Carreras; R.R. Forastiero Antiphospholipid antibodies (aPL) are a heterogeneous family of antibodies, including those specific for a variety of phospholipid (PL)-binding proteins and also those reacting with PL molecules. The former seem to be associated with the antiphospholipid syndrome (APS...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1994) 24 (3): 175–182.
Published Online: 28 April 2009
...J.F. Schved; C. Dupuy-Fons; C. Biron; I. Quéré; C. Janbon The objective of this study was to determine the prevalence and clinical significance of elevated antiphospholipid antibodies (APA) in a large series of patients admitted to a departament of Internal Medicine. At the end of entry phase, 1014...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1994) 24 (3): 191–203.
Published Online: 28 April 2009
.... Antiphospholipid antibodies Cofactors β2Glycoprotein I Standardization J . Amiral /. Larrivaz D. Cluzeau M. Adam Serbio Research Laboratory Stago Group Gennevilliers, France Original Paper Haemostasis 1994;24:191-203 Standardization of Immunoassays for Antiphospholipid Antibodies with ß2GPI and Role of Other...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1994) 24 (3): 204–207.
Published Online: 28 April 2009
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antiphospholipid antibodies Experimental animal model β2-glycoprotein I A.E. Gharavi A.L. Aron LSU Medical Center, New Orleans, La., USA...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1991) 21 (1): 19–24.
Published Online: 24 April 2009
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antiphospholipid antibodies Anticardiolipin antibodies Lupus anticoagulant Thrombosis, venous Haemostasis 1991;21:19...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1991) 21 (1): 25–29.
Published Online: 24 April 2009
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Lupus anticoagulant Anticardiolipin antibodies Thrombosis Antiphospholipid antibodies Fetal loss Haemostasis...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (2007) 36 (3-4): 131–136.
Published Online: 27 January 2009
... catheter are a special group with increased venous thrombotic event (VTE) risk. Among acquired risk factors, antiphospholipid antibodies are common in cancer patients, especially in lymphoproliferative diseases. Published data suggests that the risk of thrombotic events, venous and arterial, is increased...
Journal Articles
María-José García-Fuster, María-José Forner, Conrado Fernández, Joaquín Gil, Amparo Vaya, Luis Maldonado
Pathophysiology of Haemostasis and Thrombosis (2005) 34 (1): 6–12.
Published Online: 18 November 2005
... episode of VTE and cessation of oral anticoagulation, 98 patients, mean age 32.2 ± 9.2 years were followed for a median of 117 months (range 6–165). Congenital risk factors for VTE were present in 36% of patients, acquired persistent (positive antiphospholipid antibodies during the whole follow-up) in 19...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (2000) 30 (Suppl. 2): 57–62.
Published Online: 17 November 2004
...Monica Galli The results of an analysis of studies published over a 10-year period that addressed the association between antiphospholipid antibodies (aPLs) and thromboembolic events in patients with the antiphospholipid syndrome (APS) are reported. It would appear that lupus anticoagulants...